Soren Acquisition Corp. Announces Closing of $253 Million Initial Public Offering

Rhea-AI Summary

Soren Acquisition Corp (NASDAQ:SORN) closed an initial public offering of 25,300,000 units (including a 3,300,000-unit over-allotment) at $10.00 per unit, generating $253,000,000 in gross proceeds. Units began trading on January 7, 2026 on the Nasdaq Global Market under the symbol SORNU; once separated, Class A shares and warrants are expected to list as SORN and SORNW. Each unit comprises one Class A ordinary share and one‑third of one redeemable warrant; each whole warrant is exercisable to buy one Class A share at $11.50. The company is a blank check company focused on completing a business combination, with management led by CEO Arghavan Di Rezze and CFO Jamie Weber.

Positive

• Gross proceeds of $253,000,000
• 25,300,000 units sold at $10.00 per unit
• Underwriters exercised full 3,300,000‑unit over‑allotment
• Units began trading on Nasdaq as SORNU on Jan 7, 2026

Negative

• Securities include warrants exercisable at $11.50, which may dilute shareholders
• Company is a blank check vehicle with no disclosed operating revenue

Key Figures

IPO units: 25,300,000 units Over-allotment units: 3,300,000 units IPO price: $10.00 per unit +5 more

8 metrics

IPO units 25,300,000 units Initial public offering size

Over-allotment units 3,300,000 units Underwriters' over-allotment option exercised in full

IPO price $10.00 per unit Initial public offering price

Gross proceeds $253,000,000 Total gross proceeds from IPO

Warrant coverage 1/3 redeemable warrant per unit Each unit’s warrant component

Warrant exercise price $11.50 per share Exercise price for each whole warrant

Nasdaq trading start January 7, 2026 Units began trading on Nasdaq Global Market

SEC effectiveness date January 6, 2026 Registration statement declared effective by SEC

Market Reality Check

normal vol

Market Pulse Summary

This announcement confirms the completion of Soren Acquisition Corp.’s IPO, raising $253,000,000 thr...

Analysis

This announcement confirms the completion of Soren Acquisition Corp.’s IPO, raising $253,000,000 through 25,300,000 units at $10.00 each, with attached redeemable warrants exercisable at $11.50 per share. As a healthcare-focused blank check company, the key factors to watch include the identification of a suitable business combination target, the terms of any eventual transaction, and how unit, share, and warrant trading evolve on Nasdaq.

Key Terms

over-allotment option, redeemable warrant, exercise price, blank check company, +4 more

8 terms

over-allotment option financial

"includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

redeemable warrant financial

"one-third of one redeemable warrant, with each whole warrant entitling the holder"

A redeemable warrant is a financial tool that gives its holder the right to buy shares of a company at a fixed price within a certain period. If the holder chooses to do so, the company can buy back or cancel the warrant before it expires, often to encourage investment or manage share issuance. For investors, it provides an option to potentially buy shares at a favorable price while offering some flexibility for the issuing company.

exercise price financial

"to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

blank check company financial

"The Company is a blank check company formed for the purpose of effecting a merger"

A blank check company is a publicly listed shell that raises money from investors before naming a specific business to buy or merge with, similar to handing a cashier a signed check and asking them to fill in the payee later. It matters to investors because it offers a faster, often cheaper path for private firms to become public, but carries extra risk since returns depend on the organizers’ ability to find a good deal and on limited information about the future business.

business combination financial

"reorganization or similar business combination with one or more businesses"

A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

Nasdaq Global Market financial

"began trading on January 7, 2026 on the Nasdaq Global Market (“Nasdaq”)"

The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.

registration statement regulatory

"A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

prospectus regulatory

"The offering was made only by means of a prospectus, copies of which may be obtained from"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

AI-generated analysis. Not financial advice.

Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.

The Company’s units began trading on January 7, 2026 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “SORNU.” Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “SORN” and “SORNW,” respectively.

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business within the healthcare industry.

The Company’s management team is led by Arghavan Di Rezze, its Chief Executive Officer, and Jamie Weber, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “Board”). In addition, the Board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol. Peter Ondishin and Nicholas Shekerdemian serve as Advisors to the Company.

BTIG, LLC acted as sole book-running manager for the offering. Reed Smith LLP served as legal counsel to the Company and Walkers (Cayman) LLP served as Cayman Islands counsel to the Company. Ellenoff Grossman & Schole LLP served as legal counsel to the underwriter.

The offering was made only by means of a prospectus, copies of which may be obtained from: BTIG, LLC, 65 East 55th Street New York, New York 10022, or by email at prospectusdelivery@btig.com.

A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on January 6, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds of the offering and the Company’s search for an initial business combination. No assurance can be given that the net proceeds of the offering will be used as indicated.

Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor Contacts

Soren Acquisition Corp.
Arghavan Di Rezze, Chief Executive Officer
apd@direzzefamilyoffice.com

FAQ

What did Soren Acquisition Corp (SORN) announce on January 9, 2026 about its IPO?

The company closed an IPO of 25,300,000 units at $10.00 per unit, raising $253,000,000 in gross proceeds.

How are Soren Acquisition Corp units structured and what are the warrant terms?

Each unit contains one Class A share and one‑third of a redeemable warrant; each whole warrant allows purchase of one share at $11.50 per share.

When and under what symbols did Soren’s securities begin trading on Nasdaq?

Units began trading on January 7, 2026 as SORNU; separated Class A shares and warrants are expected to trade as SORN and SORNW.

Who leads Soren Acquisition Corp’s management team and board?

The management team is led by CEO Arghavan Di Rezze and CFO Jamie Weber; the board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol.

What is Soren Acquisition Corp’s stated business purpose after the IPO?

The company is a blank check company formed to effect a business combination, focused on targets within the healthcare industry.